Related Experiment Video
Updated: Jun 3, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Urine drug testing in chronic pain
Paul J Christo1, Laxmaiah Manchikanti, Xiulu Ruan
1Department of Anesthesiology and Critical Care Medicine Division of Pain Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. pchristo@jhmi.edu
Urine drug testing (UDT) is vital for monitoring opioid therapy in chronic pain patients, helping to prevent abuse while ensuring proper treatment. This review examines UDT
Area of Science:
- Pain Management
- Pharmacology
- Clinical Toxicology
Background:
- Chronic non-cancer pain management presents challenges regarding opioid therapy, balancing patient treatment with preventing abuse, overuse, and diversion.
- Physician apprehension towards chronic opioid therapy stems from concerns about evidence, misuse, tolerance, dependence, and hyperalgesia, contrasted by criticism of opioid underuse and pain undertreatment.
- Preventing controlled prescription drug abuse is a shared responsibility among governmental bodies, professional associations, pharmaceutical companies, physicians, and the public.
Purpose of the Study:
- To review the critical role of urine drug testing (UDT) in monitoring adherence to opioid therapy for chronic pain.
- To evaluate the reliability, accuracy, appropriate use, and limitations of UDT in clinical practice.
- To provide insights into managing opioid misuse and abuse in chronic pain management.
Main Methods:
- Comprehensive literature review on urine drug testing (UDT) in the context of chronic opioid therapy.
- Analysis of UDT's role in adherence monitoring, alongside prescription monitoring programs and other screening tools.
- Examination of UDT's limitations, including drug metabolism, test reliability, and physician knowledge.
Main Results:
- Urine drug testing (UDT) is a primary tool for monitoring patient compliance with opioid therapy and detecting potential misuse or abuse.
- UDT aids in assessing a patient's predisposition to and patterns of drug misuse/abuse, crucial for safe and effective opioid use.
- Despite limitations, UDT remains a widely available and familiar method for tracking opioid use in chronic pain patients.
Conclusions:
- Adherence monitoring, particularly through UDT, is crucial for the appropriate delivery and future preservation of opioid therapy.
- UDT is a vital component in establishing and maintaining the safe and effective use of opioid analgesics for chronic pain.
- Understanding UDT's role, reliability, and limitations is essential for pain physicians to optimize chronic opioid therapy.
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management

